CNRL in silico exercise to determine the capabilities of network laboratories to detect triple reassortant swine origin influenza A(H3N2) viruses
Following the emergence of swine influenza A(H3N2) variant (v) viruses with sporadic human infections in North America, the Community Network of Reference Laboratories (CNRL) and the Animal Health and Veterinary Laboratories Agency completed an exercise to assess the CNRL’s capability to detect novel reassortant and circulating triple reassortant swine viruses (TRA) in humans.
Scientific advice on type F botulism
This report analyses the availability and effectiveness of different types of antitoxins to neutralise type F botulism. A literature review was performed in consultation with the European Medicines Agency.
Avian Influenza in Cats - ECDC advice for avoiding exposure of humans
Risk assessment: Avian Influenza A/H5N1 in Bathing and Potable (Drinking) Water and Risks to Human Health
Avian influenza: Guidance for National Authorities to Produce Messages for the Public Concerning the Protection of Vulnerable Groups
The document provides some principles to consider when communicating to the public about the public health risks from avian influenza.
Oseltamivir Prophylaxis Following Suspected Exposure of Humans to Highly Pathogenic Avian Influenza
Oseltamivir Prophylaxis Following Suspected Exposure of Humans to Highly Pathogenic Avian Influenza (HPAI) with Particular Reference to HPAI type A/H5N1.
Community engagement and institutional collaboration during outbreaks of Shiga toxin/verocytotoxin-producing Escherichia coli in Ireland
This country visit report presents the findings of a case study into outbreaks of Shiga toxin/verocytotoxin-producing Escherichia coli (STEC/VTEC) at childcare facilities in Ireland, conducted in November 2018.